0001209191-23-049996.txt : 20230919
0001209191-23-049996.hdr.sgml : 20230919
20230919170407
ACCESSION NUMBER: 0001209191-23-049996
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230915
FILED AS OF DATE: 20230919
DATE AS OF CHANGE: 20230919
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DENNER ALEXANDER J
CENTRAL INDEX KEY: 0001361754
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34620
FILM NUMBER: 231264576
MAIL ADDRESS:
STREET 1: C/O SARISSA CAPITAL MANAGEMENT LP
STREET 2: 660 STEAMBOAT ROAD, 3RD FLOOR
CITY: GREENWICH
STATE: CT
ZIP: 06830
FORMER NAME:
FORMER CONFORMED NAME: Denner Alexander J
DATE OF NAME CHANGE: 20060504
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sarissa Capital Management LP
CENTRAL INDEX KEY: 0001577524
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34620
FILM NUMBER: 231264575
BUSINESS ADDRESS:
STREET 1: 660 STEAMBOAT ROAD
CITY: GREENWICH
STATE: CT
ZIP: 06830
BUSINESS PHONE: 203-302-2330
MAIL ADDRESS:
STREET 1: 660 STEAMBOAT ROAD
CITY: GREENWICH
STATE: CT
ZIP: 06830
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IRONWOOD PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001446847
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043404176
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 SUMMER STREET, SUITE 2300
CITY: BOSTON
STATE: MA
ZIP: 02110
BUSINESS PHONE: 617-621-7722
MAIL ADDRESS:
STREET 1: 100 SUMMER STREET, SUITE 2300
CITY: BOSTON
STATE: MA
ZIP: 02110
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-09-15
0
0001446847
IRONWOOD PHARMACEUTICALS INC
IRWD
0001361754
DENNER ALEXANDER J
C/O IRONWOOD PHARMACEUTICALS, INC.
100 SUMMER STREET, SUITE 2300
BOSTON
MA
02110
1
0
1
0
0001577524
Sarissa Capital Management LP
660 STEAMBOAT ROAD
3RD FLOOR
GREENWICH
CT
06830
0
0
1
0
0
Class A Common Stock
2023-09-15
4
A
0
1798
0.00
A
118930
D
Class A Common Stock
16390000
I
See footnote
Issued pursuant to the Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2023.
Consists of shares that are held by Sarissa Capital Management LP ("Sarissa Capital") or by the funds and other investment vehicles (the "Sarissa Funds") for which Sarissa Capital serves as investment advisor. Dr. Denner is the Chief Investment Officer of Sarissa Capital and the managing member, general partner or other control party of the Sarissa Funds. By virtue of the foregoing, Dr. Denner may be deemed to indirectly beneficially own the shares that these funds directly beneficially own. Each of Sarissa Capital, the Sarissa Funds and Dr. Denner disclaims beneficial ownership of these shares except, in each case, to the extent of their pecuniary interest therein.
SARISSA CAPITAL MANAGEMENT LP, By: /s/ Mark DiPaolo,
Name: Mark DiPaolo, Title: Senior Partner, General Counsel
2023-09-19
/s/ Alexander Denner
2023-09-19